ArticleJournal of orthopaedic surgery and research2025
Clinical safety and efficacy of simultaneous bilateral total knee arthroplasty in an Asian population: a propensity score-matched analysis.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundClear clinical guidelines on performing simultaneous bilateral total knee arthroplasty (BTKA) are lacking. We compare the clinical outcomes between BTKA and unilateral total knee arthroplasty (UTKA) using propensity score matching to assess safety and clinical efficacy, hypothesizing no difference in clinical safety.
methodsAmong 1,665 BTKA and UTKA cases, patients were matched in a 1:1 ratio by age, sex, body mass index, follow-up, and comorbidities, resulting in 653 patients per group. Primary outcomes included 30-day complication rates and intensive care unit (ICU) admission rates. Secondary outcomes included length of stay (LOS), transfusion rate, estimated blood loss, hemoglobin (Hb) levels (preoperative and two days postoperative), Hb decrease, and 1-year mortality rate. The patient-reported outcomes (PROMs) was measured preoperatively and at 3, 6, and 12 months postoperatively using the American Knee Society Score, Western Ontario and McMaster Universities Osteoarthritis Index, and EuroQol 5-Dimension.
resultsThere were no differences in the 30-day complication rates and ICU admission rate between the BTKA and UTKA groups after matching (1.4% vs. 0.9%; p = 0.60, 0.5% vs. 0.6%; p = 1.00). However, patients who underwent BTKA had a longer LOS, a higher incidence of transfusion (7.2% vs. 2.1%; p < 0.001), greater blood loss (128.6 ± 75.5 vs. 72.5 ± 45.6 mL; p < 0.001), and a more pronounced decrease in Hb levels (3.1 vs. 2.9 g/dL; p < 0.001) than those who underwent UTKA. No significant differences were observed in PROMs at one year postoperatively.
conclusionsPatients who underwent BTKA reported similar 30-day complication rates, ICU admissions, and PROMs compared to UTKA. Despite higher LOS, transfusion rates, blood loss, and Hb decrease, BTKA remains a safe, effective option. It should be performed cautiously, considering patient comorbidities and overall health in treating bilateral knee OA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.